Horti Andrew G, Wang Yuchuan, Minn Il, Lan Xi, Wang Jian, Koehler Raymond C, Alkayed Nabil J, Dannals Robert F, Pomper Martin G
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland.
J Nucl Med. 2016 Nov;57(11):1817-1822. doi: 10.2967/jnumed.116.173245. Epub 2016 Jul 14.
Soluble epoxide hydrolase (sEH) is a bifunctional enzyme located within cytosol and peroxisomes that converts epoxides to the corresponding diols and hydrolyzes phosphate monoesters. It serves to inactivate epoxyeicosatrienoic acids (EETs), which are generated in the brain to couple neuronal activity and cerebral blood flow in normal and pathologic states. Altered regulation of sEH was observed previously in various neuropathologic disorders including vascular dementia and stroke. Inhibitors of sEH are pursued as agents to mitigate neuronal damage after stroke. We developed N-(3,3-diphenylpropyl)-6-F-fluoronicotinamide (F-FNDP), which proved highly specific for imaging of sEH in the mouse and nonhuman primate brain with PET.
F-FNDP was synthesized from the corresponding bromo precursor. sEH inhibitory activity of F-FNDP was measured using an sEH inhibitor screening assay kit. Biodistribution was undertaken in CD-1 mice. Binding specificity was assayed in CD-1 and sEH knock-out mice and Papio anubis (baboon) through pretreatment with an sEH inhibitor to block sEH binding. Dynamic PET imaging with arterial blood sampling was performed in 3 baboons, with regional tracer binding quantified using distribution volume. The metabolism of F-FNDP in baboons was assessed using high-performance liquid chromatography.
F-FNDP (inhibition binding affinity constant, 1.73 nM) was prepared in 1 step in a radiochemical yield of 14% ± 7%, specific radioactivity in the range of 888-3,774 GBq/μmol, and a radiochemical purity greater than 99% using an automatic radiosynthesis module. The time of preparation was about 75 min. In CD-1 mice, regional uptake followed the pattern of striatum > cortex > hippocampus > cerebellum, consistent with the known brain distribution of sEH, with 5.2% injected dose per gram of tissue at peak uptake. Blockade of 80%-90% was demonstrated in all brain regions. Minimal radiotracer uptake was present in sEH knock-out mice. PET baboon brain distribution paralleled that seen in mouse, with a marked blockade (95%) noted in all regions indicating sEH-mediated uptake of F-FNDP. Two hydrophilic metabolites were identified, with 20% parent compound present at 90 min after injection in baboon plasma.
F-FNDP can be synthesized in suitable radiochemical yield and high specific radioactivity and purity. In vivo imaging experiments demonstrated that F-FNDP targeted sEH in murine and nonhuman primate brain specifically. F-FNDP is a promising PET radiotracer likely to be useful for understanding the role of sEH in a variety of conditions affecting the central nervous system.
可溶性环氧化物水解酶(sEH)是一种双功能酶,位于细胞质和过氧化物酶体中,可将环氧化物转化为相应的二醇并水解磷酸单酯。它用于使环氧二十碳三烯酸(EETs)失活,EETs在大脑中产生,在正常和病理状态下将神经元活动与脑血流量联系起来。先前在包括血管性痴呆和中风在内的各种神经病理疾病中观察到sEH调节异常。sEH抑制剂被作为减轻中风后神经元损伤的药物进行研究。我们开发了N-(3,3-二苯基丙基)-6-F-氟烟酰胺(F-FNDP),经证明它在小鼠和非人类灵长类动物大脑中对sEH进行PET成像具有高度特异性。
F-FNDP由相应的溴代前体合成。使用sEH抑制剂筛选测定试剂盒测量F-FNDP的sEH抑制活性。在CD-1小鼠中进行生物分布研究。通过用sEH抑制剂预处理以阻断sEH结合,在CD-1和sEH基因敲除小鼠以及狒狒(Papio anubis)中测定结合特异性。对3只狒狒进行了动脉血采样的动态PET成像,使用分布容积对区域示踪剂结合进行定量。使用高效液相色谱法评估F-FNDP在狒狒中的代谢。
使用自动放射性合成模块,一步法制备了F-FNDP(抑制结合亲和力常数,1.73 nM),放射化学产率为14%±7%,比活度在888 - 3,774 GBq/μmol范围内,放射化学纯度大于99%。制备时间约为75分钟。在CD-1小鼠中,区域摄取遵循纹状体>皮质>海马体>小脑的模式,与已知的sEH脑部分布一致,峰值摄取时每克组织为注射剂量的5.2%。在所有脑区均显示80% - 90%的阻断。在sEH基因敲除小鼠中放射性示踪剂摄取极少。狒狒大脑的PET分布与小鼠相似,所有区域均有明显阻断(95%),表明F-FNDP是由sEH介导摄取的。鉴定出两种亲水性代谢物,注射后90分钟狒狒血浆中存在20%的母体化合物。
F-FNDP可以以合适的放射化学产率、高比活度和纯度合成。体内成像实验表明,F-FNDP在小鼠和非人类灵长类动物大脑中特异性靶向sEH。F-FNDP是一种有前景的PET放射性示踪剂,可能有助于了解sEH在影响中枢神经系统的各种病症中的作用。